Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation

Nada Hamad, MBBS Hons, FRACP, FRCPA, Mohamed Shanavas, MD, FRACP, FRCPA, Fotios V. Michelis, MD, PhD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, Dennis Kim, MD

Blood (2013) 122 (21): 3303.

https://doi.org/10.1182/blood.V122.21.3303.3303

Published: 2013

Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning

Nada Hamad, MBBS Hons, FRACP, FRCPA, Ryan Del Bel, B.Math, Hans A. Messner, M.D./Ph.D, Dennis Kim, MD, John Kuruvilla, MD, Jeffrey H. Lipton, MD, PhD, Jieun Uhm, MD, Wei Xu, Vikas Gupta, MD, FRCP, FRCPath

Blood (2013) 122 (21): 2044.

https://doi.org/10.1182/blood.V122.21.2044.2044

Published: 2013

Journal Articles

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

Joon Ho Moon, M.D., Ph.D., Sang Kyun Sohn, MD, PhD, Naheed Alam, MBBS, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2013) 122 (21): 2066.

https://doi.org/10.1182/blood.V122.21.2066.2066

Published: 2013

Journal Articles

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation

Naheed Alam, MBBS, Anna Lambie, NP, Yvette Neme Yunes, MD, Feras Alfraih, MD, Eshetu G Atenafu, MSc, Dennis Dong Hwan Kim, MD, PhD, Vikas Gupta, MD, FRCP, FRCPath, John Kuruvilla, MD, Jeff H Lipton, MD, Hans A. Messner, M.D./Ph.D

Blood (2012) 120 (21): 4501.

https://doi.org/10.1182/blood.V120.21.4501.4501

Published: 2012

Journal Articles

Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd

Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2012) 120 (21): 1946.

https://doi.org/10.1182/blood.V120.21.1946.1946

Published: 2012

Journal Articles

Prognostic Power of Chronic Gvhd Risk Score Model by Ibmtr Can Be Improved with Addition of Absolute Lymphocyte Counts and Eosinophil Counts At the Onset of Chronic Gvhd

Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2012) 120 (21): 4184.

https://doi.org/10.1182/blood.V120.21.4184.4184

Published: 2012

Journal Articles

Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia

Dong Hwan Kim, MD, PhD, Kyoung Ha Kim, M.D., Myung Hee Chang, M.D., Wei Xu, PhD, Clement Ma, MSc, Xiangdong Liu, Ph.D., Katherine Siminovitch, M.D./Ph.D., Hans A. Messner, M.D./Ph.D, Jeffrey H. Lipton, MD, PhD

Blood (2008) 112 (11): 4223.

https://doi.org/10.1182/blood.V112.11.4223.4223

Published: 2008

Journal Articles

Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.

Kevin H.M. Kuo, MD, Jeannie Callum, M.D., FRCPC, Joseph Brandwein, M.D., FRCPC, Michael Crump, M.D., FRCPC, John E. Curtis, M.D., FRCPC, Vikas Gupta, M.D., MRCP, Jeffrey H. Lipton, M.D., Ph.D., FRCPC, Dominic Pantalony, M.D., FRCPC, Aaron Schimmer, M.D., FRCPC, Andre Schuh, M.D., FRCPC, Graham Sher, M.D., Ph.D., FRCPC, David M. Sutton, M.D., FRCPC, Karen W.L. Yee, M.D., FRCPC, Armand Keating, M.D., FRCPC, Mark D. Minden, M.D., Ph.D., FRCPC, Hans A. Messner, M.D., Ph.D., FRCPC

Blood (2006) 108 (11): 2007.

https://doi.org/10.1182/blood.V108.11.2007.2007

Published: 2006

NARROW

Mycophenolate Compared to Methotrexate As Part of Cyclosporine Based-GVHD Prophylaxis Does Not Affect Transplant Outcomes, Reduces Organ Specific Acute And Chronic GVHD, but Increases The Risk of CMV Viremia In Matched Related Donor Peripheral Blood Stem Cell Transplantation

Outcomes of Allogeneic Hematopoietic Cell Transplantation In Aplastic Anemia Using Intermediate Dose Alemtuzumab Based-Conditioning

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

CMV Reactivations and Their Impact On Outcomes in Patients After Hematopoietic Cell Transplantation

Independent Validation of Chronic Graft-Versus-Host Disease (GVHD) Grading System Proposed by the NIH Consensus Criteria in Terms of Prognostic Stratification of the Patients Developed Chronic Gvhd

Prognostic Power of Chronic Gvhd Risk Score Model by Ibmtr Can Be Improved with Addition of Absolute Lymphocyte Counts and Eosinophil Counts At the Onset of Chronic Gvhd

Genetic Variants in the Candidate Genes of the Apoptosis Pathway and Susceptibility to Chronic Myeloid Leukemia

Management of Hyperleukocytosis in Acute Myelogenous Leukemia Using Hydroxyurea Rather Than Leukopheresis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only